Atai Life Sciences raised $157 million in a Series D financing round led by founder Christian Angermayer and Thiel Capital, AI (big data) Biotech Health services Software Services Investments 03 March 2021 Share:
Round value (USD): 157m Round investors: Apeiron Investment Group Subversive Capital Thiel Capital Fearless Ventures Falcon Edge Capital Pura Vida Pro LLC Catalio Capital Management Highline Capital Korify Capital Company: Atai Life Sciences Industry: AI (big data) Biotech Health services Software Services
Wellhub raises $220M, with a $2.2 Billion valuation Health services Marketplace Software Services Sports Industry Investments 25 June 2021
Atai Life Sciences announced securing $125 million in series c funding. AI (big data) Biotech Health services Software Services Investments 30 October 2020